(6bR,10aS)-3-Methyl-2,3,6b,7,8,9,10,10a-octahydro-1H-pyrido[3',4':4,5]pyrrolo[1,2,3-de]quinoxaline, 97.0%, 1g

2-chloro-N-(2,4-dimethoxyphenyl)nicotinamide, 95.0%, 5g

Oxazole-4-carbaldehyde, 95.0%, 50g

4-(DIBROMOMETHYL)-2-FLUOROBENZONITRILE, 95.0%, 5g

Ytterbium foil 99.9% 0.25 x 25 x 50 mm 1 pc

7-Methylquinazolin-4(3H)-one, 95.0%, 1g

(S)-2-((1R,3aR,4S,7aR)-4-((tert-butyldimethylsilyl)oxy)-7a-methyloctahydro-1H-inden-1-yl)propan-1-ol, 98%, 100mg

(3'-Methyl-[1,1'-biphenyl]-4-yl)boronic acid, 95.0%, 1g

2,4'-Difluorobenzophenone, 97.0%, 5g

3,5-Difluoro-4-(difluoromethyl)pyridine, 98.0%, 5g

(3'-Methoxy-biphenyl-3-yl)-acetic acid, 98.0%, 100mg

3-(1-Benzothiophen-3-yl)propanoic acid, 97%, 250mg

(S)-1-Amino-8-(diphenylphosphino)-1,2,3,4-tetrahydronaphthalene, 97%, 100mg